Cholesterol effect on Apolipoprotein B secretion and binding of low-density lipoproteins hepatoma HepG2 Cells
DOI:
https://doi.org/10.7124/bc.0000AAAbstract
The effect of cholesterol, oleic acid and recombinant complexes containing apolipoprotein Al/dimyristoylphosphatidylcholine (apoAl/DMPC) on apolipoprotein B (apoB) secretion and uptake of 125I-labeled low-density lipoproteins (LDL) by cultured human hepatoma HepG2 cells was studied. Addition of different concentrations of exogenous cholesterol (as ethanol solution) to the cells increased apoB secretion and inhibited 1 25I-labelled LDL uptake in a dose-dependent manner. Similar effects were found when the cells were incubated with different concentrations of oleic acid, which enhanced the intracellular cholesterol content. The presence of complexes apoAl/DMPC in the culture medium, which decreased the cellular pool of cholesterol, resulted in the opposite effects: apoB secretion was inhibited, while the LDL-receptor activity was stimulated. Significant negative correlation (r = —0.92, p<0.001) was found between apoB secretion and LDL uptake. The obtained data suggest that cholesterol can induce cooperated changes in apoB secretion and LDL-rcceptor activity.References
Edge SB, Hoeg JM, Schneider PD, Brewer HB Jr. Apolipoprotein B synthesis in humans: liver synthesizes only apolipoprotein B-100. Metabolism. 1985;34(8):726-30.
Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25(12):1277-94.
Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A. 1980;77(1):604-8.
Kosykh VA, Preobrazhensky SN, Fuki IV, Zaikina OE, Tsibulsky VP, Repin VS, Smirnov VN. Cholesterol can stimulate secretion of apolipoprotein B by cultured human hepatocytes. Biochim Biophys Acta. 1985;836(3):385-9.
Preobrazhensky SN, Ivanov VO, Fuki IV, Tsibulsky VP, Kameneva AM, Repin VS, Ermolin GA. Enzyme-linked immunoreceptor assay of low-density-lipoprotein receptors. Anal Biochem. 1985;149(1):269-74.
Stephens RE. High-resolution preparative SDS-polyacrylamide gel electrophoresis: fluorescent visualization and electrophoretic elution-concentration of protein bands. Anal Biochem. 1975;65(1-2):369-79.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-75.
Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972;260(2):212-21.
Antonov IV, Medvedeva NV, Misharin AJu, Morozkin AD, Ruuge EK. Recombinant models of lipoproteins. Apolipoprotein A-I/phosphatidylcholine/cholesterol complexes formed in a 2-chloroethanol-water mixture. Biochim Biophys Acta. 1985;835(1):50-7.
Preobrazhensky SN, Tsibulsky VP, Fuki IV, Ivanov VO, Repin VS, Smirnov VN. Enzyme immunoassay of the receptors for modified low density lipoprotein. Anal Biochem. 1986;154(2):382-7.
Ellsworth JL, Erickson SK, Cooper AD. Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acid. J Lipid Res. 1986;27(8):858-74.
Orekhov AN, Misharin AYu, Tertov VV, Khashimov KhA, Pokrovsky SN, Repin VS, Smirnov VN. Artificial HDL as an anti-atherosclerotic drug. Lancet. 1984;2(8412):1149-50.
Lutalo-Bosa AJ, Adolphson JL, Albers JJ. Evaluation of the measurement of B protein of plasma low density lipoprotein by radial immunodiffusion. J Lipid Res. 1985;26(8):995-1001.
